Preliminary Safety of PDS0101 (Versamune +HPVmix) and Pembrolizumab Combination Therapy in Subjects with Recurrent/Metastatic Human Papillomavirus-16 Positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)

Autor: L. Wood, A.V. Chintakuntlawar, K. Price, J. Kaczmar, G. Conn, F.K. Bedu-Addo, J. Weiss
Rok vydání: 2022
Předmět:
Zdroj: International Journal of Radiation Oncology*Biology*Physics. 112:e37-e38
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2021.12.087
Databáze: OpenAIRE